June 2027
Balcoltra
ethinyl estradiol and levonorgestrel
Tablet (oral) · NDA 208612
Last listed protection ends
June 1, 2027
The FDA lists 1 patent for Balcoltra, and this is the day the last one ends. It is not the date a generic goes on sale.
Patents and exclusivities
- Patent 7,838,042Claims the drug substance and a use (U-3251)